AGAndrew G. Georgiadis

Andrew G. Georgiadis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrew G. Georgiadis has a total of 149 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    San Diego Acetabuloplasty

    by Andrew G. Georgiadis, Tom F. Novacheck, Vidyadhar V. Upasani, Patrick F. Curran, Jennifer C. Laine

  • Magnetically Controlled Intramedullary Compression Nailing for Femoral Nonunion in Osteogenesis Imperfecta

    by Nickolas J. Nahm, Andrew G. Georgiadis, Mark T. Dahl

    Case: A 51-year-old nonambulatory woman with type III osteogenesis imperfecta sustained a diaphyseal femur fracture during a transfer, distal to a childhood-placed intramedullary pin. At the time of presentation, the fracture was a painful atrophic nonunion, preventing effective transfer. Retrograde nailing with a motorized magnetic lengthening nail, inserted with preset distraction, allowed gradual compression, solid union, and pain relief. Conclusion: This report describes the method of off-label lengthening nail modification used for gradual compression of a femoral nonunion site, achieving healing in pathologic bone.

  • Open Access

    Retrograde Intramedullary Femoral Lengthening With Acute Deformity Correction in Children, Adolescents, and Young Adults

    by Mark T. Dahl, Elizabeth P. Wellings, Cole Funk, Andrew G. Georgiadis

    Background: Acquired and congenital limb length discrepancies often coexist with deformities of the distal femur. Lengthening of the femur along its anatomic axis changes the limb's mechanical alignment. Angular correction and lengthening can be achieved at the same site if a retrograde lengthening nail is used with a specific preoperative planning method (“reverse planning”) which permits patient-specific selection of the final mechanical axis. Methods: A consecutive cohort series of children, adolescents, and young adults (mean 15.6 ± 4.8 years) undergoing retrograde implantable femoral lengthening between the years 2011 and 2024 were analyzed. Surgical details, lengthening parameters, Limb Lengthening and Reconstruction Society (LLRS)–AIM index, accuracy of final correction, and complications were reviewed and classified. Patients were eligible only if the distal femoral physis was closed. Results: Seventy-three lengthening were eligible in the study period. Average lengthening was 4.2 ± 1.4 cm (range 2.0-8.0 cm), and consolidation index was 39.4 ± 21.9 days/cm. Deformities and length discrepancies were moderately complex, with a mean LLRS AIM score of 6 (range 1-13). Complication rates were similar to previous reports of intramedullary femoral lengthening, comparable between congenital (12 of 31, 39%) and acquired etiologies (16 of 42, 38%). Preoperative coronal alignment ranged from 14° varus to 20° valgus, while final coronal alignment was 0.4° ± 3.4° of neutral (range 7° valgus to 13° varus). Coronal deformities up to 20° and sagittal deformities up to 23° were corrected acutely at the lengthening site. Conclusions: Retrograde intramedullary femoral lengthening with acute deformity correction at the same site is an alternative to antegrade lengthening with separate osteotomy of the distal femur in children and adolescents. The reverse planning method allows reproducible length and deformity correction at the same location. Specific intraoperative technical adjuncts are used to achieve and maintain the desired alignment. Level of Evidence: Diagnostic Level IV . See Instructions for Authors for a complete description of levels of evidence.

  • Open Access

    Orthopedic surgery after selective dorsal rhizotomy in children with cerebral palsy: A matched cohort study

    by Michael H. Schwartz, Andrew G. Georgiadis

    Aim: To test whether selective dorsal rhizotomy (SDR) changes the incidence of subsequent orthopedic surgery in children with cerebral palsy. Method: This was a matched cohort study. Using historical data from a single center, we identified two groups of individuals based on their history of SDR (yes‐SDR and no‐SDR), matched at baseline on key clinical variables. We defined 10 orthopedic surgery categories that accounted for more than 95% of surgery recorded in our gait center database. We then fitted Kaplan–Meier estimates of cumulative incidence for each surgery, stratified according to SDR status. Results: We obtained excellent comprehensive baseline matching. Foot and ankle bone surgery and femoral derotation osteotomy exhibited 15% to 20% higher cumulative incidence after SDR. Rectus femoris transfer exhibited approximately 30% lower cumulative incidence after SDR. The remaining surgeries, including all surgeries for treating muscle contractures, were unaffected by SDR, exhibiting only small ( 0.05, log‐rank test) differences in cumulative incidence. Interpretation: SDR does not consistently lower the cumulative incidence of orthopedic surgery and does not lower the rate of surgery for muscle contracture. The mechanisms through which SDR influences subsequent surgery remain unclear, highlighting a critical area for future research.

  • Open Access

    Evidence Based Gait Analysis Interpretation Tools (EB-GAIT) treatment recommendation and outcome prediction models to support decision-making based on clinical gait analysis data

    by Michael H. Schwartz, Andrew G. Georgiadis

    Clinical gait analysis (CGA) has historically relied on clinician experience and judgment, leading to modest, stagnant, and unpredictable outcomes. This paper introduces Evidence-Based Gait Analysis Interpretation Tools (EB-GAIT), a novel framework leveraging machine learning to support treatment decisions. The core of EB-GAIT consists of two key components: (1) treatment recommendation models, which are models that estimate the probability of specific surgeries based on historical standard-of-practice (SOP), and (2) treatment outcome models, which predict changes in patient characteristics following treatment or natural history. Using Bayesian Additive Regression Trees (BART), we developed and validated treatment recommendation models for 12 common surgeries that account for more than 95% of the surgery recorded in our CGA center’s database. These models demonstrated high balanced accuracy, sensitivity, and specificity. We used Shapley values for the models to enhances interpretability and allow clinicians and patients to understand the factors driving treatment recommendations. We also developed treatment outcome models for over 20 common outcome measures. These models were found to be unbiased, with reliable prediction intervals and accuracy comparable to experimental measurement error. We illustrated the application of EB-GAIT through a case study, showcasing its utility in providing treatment recommendations and outcome predictions. We then use simulations to show that combining recommendation and outcome models offers the possibility to improve outcomes for treated limbs, maintain outcomes for untreated limbs, and reduce the number of surgeries performed. For example, under the counterfactual situation where femoral derotation osteotomies are administered only when they align with historical standard of practice (> 50% probability of surgery) and are predicted to improve the Gait Deviation Index (change > 7.5 points), the model predicts a 11 percentage point reduction in surgeries (26% limbs currently, 15% limbs simulated), a 6 point improvement in Gait Deviation Index among treated limbs (6 currently, 12 simulated), and no change in Gait Deviation Index for untreated limbs (2 currently, 2 simulated). EB-GAIT represents a significant step toward precision medicine in CGA, offering a promising tool to enhance treatment outcomes and patient care. The EB-GAIT approach addresses the limitations of the conventional CGA interpretation method, offering a more structured and data-driven decision-making process. EB-GAIT is not intended to replace clinical judgment but to supplement it, providing clinicians with a second opinion grounded in historical data and predictive analytics. While the models perform well, their effectiveness is constrained by historical variability in treatment decisions and the inherent complexity of patient outcomes. Future efforts should focus on refining model inputs, incorporating surgical details, and pooling data from multiple centers to improve generalizability.


  • Distal Tibial Slipped Epiphysis in Stickler Syndrome

    by Nickolas J. Nahm, Andrew G. Georgiadis, Mark T. Dahl

    Case: Stickler syndrome is a collagen disorder associated with hypermobility and juvenile osteoarthritis in multiple joints. This report presents a 12-year-old adolescent boy with Stickler syndrome presenting with bilateral ankle pain. He had bilateral distal tibial recurvatum-valgus deformity and distal tibial slipped epiphysis (DTSE). He underwent osteotomy along the true plane of deformity and internal fixation. At the latest follow-up, he had decreased pain and improved clinical and radiographic alignment. Conclusions: DTSE is a rare condition contributing to ankle deformity. Previously reported in renal osteodystrophy and myelomeningocele, DTSE is reported herein for the first time in association with Stickler syndrome.

  • Open Access

    Virtual Reality as an Adjunct to Pediatric Cast Removal

    by Andrew G. Georgiadis, Peter E. Schavee, Trever M. Koester, William T. DeBruin, Chantel C. Burkitt, Walter H. Truong, Jennifer C. Laine

    Background: Cast removal may produce pain or anxiety in children. Virtual reality (VR) has been studied in other pediatric settings, but little evidence exists for its use during pediatric cast removal. Methods: A randomized controlled trial was performed in children aged 4 to 12 years, assessing the effect of VR compared with standard of care (SOC) on pain and anxiety during first-time cast removal. Children were randomized to SOC earmuffs or a VR headset. VR was hypothesized to produce less sympathetic response, lower pain, and less anxiety. Metrics were assessed by a standardized protocol. Primary aim: sympathetic response as measured by continuous heart rate (HR) before, during, and after cast removal. Secondary aims: pain as assessed using the FACES (0-10) and Visual Analog Scale (VAS; 0-100) score, and anxiety as assessed by the VAS score (0-100). Results: Ninety patients were analyzed in each of the SOC and VR groups for the primary outcome. The average age was 7.84 years (range 4-12). There were no differences in sympathetic response by baseline, removal, or change in HR between groups (+11.23 bpm for SOC vs. + 7.84 bpm for VR, p = 0.113). There were no differences in baseline, removal, or change in pain (FACES +0.86 for SOC vs. + 0.40 for VR, p = 0.220). Most patients and caregivers reported no pain, and average FACES scores were low (1.45 for SOC and 1.00 for VR). VR improved child anxiety (−4.31 ± 22.6 for VR vs. 9.96 ± 33.94 for SOC, p = 0.001) and caregiver anxiety (−17.12 ± 25.78 for VR vs. −4.99 ± 29.03 for SOC). There was high caregiver satisfaction with the removal experience in both groups (95.34 ± 15.39 in SOC vs. 95.40 ± 15.48 in VR, on a VAS 0-100). Conclusions: Use of VR did not improve sympathetic response or self-reported pain during pediatric cast removal compared with SOC. Pain during pediatric cast removal was uniformly low. Child and caregiver anxiety was improved by the use of VR. Level of Evidence: Level I–randomized controlled trial. See Instructions for Authors for a complete description of levels of evidence.


  • Open Access

    Evidence Based Gait Analysis Interpretation Tools (EB-GAIT)

    by Michael H. Schwartz, Andrew G. Georgiadis

    Clinical gait analysis (CGA) has historically relied on clinician experience and judgment, leading to modest, stagnant, and unpredictable outcomes. This paper introduces Evidence-Based Gait Analysis Interpretation Tools (EB-GAIT), a novel framework leveraging machine learning to support treatment decisions. The core of EB-GAIT consists of two key components: (1) treatment recommendation models , which are propensity models that estimate the probability of specific surgeries based on historical standard-of-practice (SOP), and (2) treatment outcome models , which predict changes in patient characteristics following treatment or natural history. Using Bayesian Additive Regression Trees (BART), we developed and validated treatment recommendation models for 12 common surgeries that account for more than 95% of the surgery recorded in our CGA center’s database. These models demonstrated high balanced accuracy, sensitivity, and specificity. We used Shapley values for the models to enhances interpretability and allow clinicians and patients to understand the factors driving treatment recommendations. We also developed treatment outcome models for over 20 common outcome measures. These models were found to be unbiased, with reliable prediction intervals and accuracy comparable to experimental measurement error. We illustrated the application of EB-GAIT through a case study, showcasing its utility in providing treatment recommendations and outcome predictions. We then use simulations to show that combining propensity and outcome models offers the possibility to improve outcomes for treated limbs, maintain outcomes for untreated limbs, and reduce the number of surgeries performed. The EB-GAIT approach addresses the limitations of the conventional CGA interpretation method, offering a more structured and data-driven decision-making process. EB-GAIT is not intended to replace clinical judgment but to supplement it, providing clinicians with a second opinion grounded in historical data and predictive analytics. While the models perform well, their effectiveness is constrained by historical variability in treatment decisions and the inherent complexity of patient outcomes. Future efforts should focus on refining model inputs, incorporating surgical details, and pooling data from multiple centers to improve generalizability. EB-GAIT represents a significant step toward precision medicine in CGA, offering a promising tool to enhance treatment outcomes and patient care. Plain Language Summary: Clinical gait analysis (CGA) helps doctors understand walking problems in patients with movement disorders, like cerebral palsy. Traditionally, treatment decisions have relied on doctors’ experience and judgment, which can lead to inconsistent and unpredictable outcomes. To address this, we developed Evidence-Based Gait Analysis Interpretation Tools (EB-GAIT), a new method that uses advanced computer models to guide treatment decisions. What is EB-GAIT?: EB-GAIT combines two types of models: (1) Treatment Recommendation Models that predict the likelihood of specific surgeries based on historical treatment patterns at our center, and (2) Outcome Prediction Models that estimate how patients’ orthopedic deformity, walking pattern, and mobility might improve after surgery or without treatment. Using a powerful statistical tool called Bayesian Additive Regression Trees (BART), we built models for 12 common surgeries and over 20 outcome measures. These models are accurate, unbiased, and provide reliable predictions. How Does EB-GAIT Help?: EB-GAIT helps doctors understand which treatments are likely to work best for each patient. The models explain why a treatment is recommended, making it easier for doctors and patients to understand. Simulations show that combining treatment recommendations and outcome predictions can lead to better results for patients, fewer unnecessary surgeries, and more consistent care. A Case Study: We use a case study throughout the paper to demonstrate EB-GAIT using a real patient example. The models accurately predicted the outcomes of surgery, showing how EB-GAIT can support doctors in making evidence-based decisions. The Future of EB-GAIT: While EB-GAIT is a powerful tool, it doesn’t replace doctors’ expertise. Instead, it provides additional information to help doctors and patients make informed choices. In the future, we plan to improve the models by adding more details about surgeries and combining data from multiple centers. We view EB-GAIT as a big step forward in using data and technology to improve care for patients with walking problems. By making treatment decisions more precise and personalized, EB-GAIT aims to help patients move better and live fuller lives.


  • Posterior Proximal Tibial Hemiepiphysiodesis

    by Andrew G. Georgiadis

    Case: Apex posterior or recurvatum deformity of the proximal tibia is an uncommon skeletal alignment. Guided growth, or hemiepiphysiodesis, is a well-established technique for correcting periarticular deformities of the knee in children. A novel technique of posterior proximal tibial hemiepiphysiodesis (PPTHE), performed though a posterior approach, is described in combination with physeal bar resection for correction of post-traumatic proximal tibial recurvatum. Two cases are reviewed including surgical technique with 21-month and 30-month outcomes. Conclusion: Proximal tibial recurvatum in children can be corrected with posterior proximal tibial hemiepiphysiodesis. The procedure may be combined with physeal bar resection in cases of post-traumatic deformity.